ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Eagle Genomics Limited

Eagle Genomics Limited is a liquidation company incorporated on 7 May 2008 with the registered office located in London, City of London. Eagle Genomics Limited was registered 17 years ago.
Status
Liquidation
In voluntary liquidation since 5 months ago
Company No
06587071
Private limited company
Age
17 years
Incorporated 7 May 2008
Size
Unreported
Confirmation
Overdue
Confirmation statement overdue by 408 days
Dated 12 July 2023 (2 years 1 month ago)
Next confirmation dated 12 July 2024
Was due on 26 July 2024 (1 year 1 month ago)
Last change occurred 2 years 1 month ago
Accounts
Overdue
Accounts overdue by 616 days
For period 1 Apr31 Mar 2022 (12 months)
Accounts type is Total Exemption Full
Next accounts for period 31 March 2023
Was due on 31 December 2023 (1 year 8 months ago)
Contact
Address
10 Lower Thames Street
London
EC3R 6AF
Address changed on 4 Apr 2024 (1 year 5 months ago)
Previous address was Biodata Innovation Centre Wellcome Genome Campus Hinxton Cambridge Cambridgeshire CB10 1DR England
Telephone
01223654481
Email
Available in Endole App
People
Officers
6
Shareholders
78
Controllers (PSC)
1
Director • Business Executive • Hungarian • Lives in Hungary • Born in May 1975
Director • French • Lives in France • Born in Nov 1968
Director • Executive • Cypriot • Lives in Greece • Born in Jul 1972
Director • Managing Partner • British • Lives in UK • Born in Nov 1967
Director • British • Lives in Scotland • Born in Sep 1980
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Etf Initial Partner Limited
Werner Robert Genieser is a mutual person.
Active
Environmental Technologies Fund 2 GP Limited
Werner Robert Genieser is a mutual person.
Active
Eagle Genomics India Holdings Ltd
Dr Victoria Kimonides is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2013–2022)
Period Ended
31 Mar 2022
For period 31 Mar31 Mar 2022
Traded for 12 months
Cash in Bank
£577K
Decreased by £1.46M (-72%)
Turnover
£2.45M
Increased by £1.08M (+79%)
Employees
76
Increased by 17 (+29%)
Total Assets
£4.31M
Decreased by £25K (-1%)
Total Liabilities
-£6.65M
Increased by £5.04M (+314%)
Net Assets
-£2.34M
Decreased by £5.07M (-186%)
Debt Ratio (%)
154%
Increased by 117.14% (+316%)
Latest Activity
Voluntary Liquidator Appointed
5 Months Ago on 20 Mar 2025
Moved to Voluntary Liquidation
5 Months Ago on 13 Mar 2025
Administrator Appointed
1 Year 5 Months Ago on 4 Apr 2024
Registered Address Changed
1 Year 5 Months Ago on 4 Apr 2024
John Schoellerman Resigned
1 Year 7 Months Ago on 8 Feb 2024
Mr John Schoellerman Appointed
1 Year 11 Months Ago on 27 Sep 2023
Anthony Charles Finbow Resigned
1 Year 11 Months Ago on 27 Sep 2023
Gavin Alan Horn Resigned
1 Year 11 Months Ago on 27 Sep 2023
Clifford Bennett Meltzer Resigned
1 Year 11 Months Ago on 27 Sep 2023
Dr Victoria Kimonides Appointed
1 Year 11 Months Ago on 27 Sep 2023
Get Credit Report
Discover Eagle Genomics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Appointment of a voluntary liquidator
Submitted on 20 Mar 2025
Notice of move from Administration case to Creditors Voluntary Liquidation
Submitted on 13 Mar 2025
Notice of administrator's death
Submitted on 13 Feb 2025
Administrator's progress report
Submitted on 23 Oct 2024
Statement of affairs with form AM02SOA/AM02SOC
Submitted on 25 Jun 2024
Result of meeting of creditors
Submitted on 4 Jun 2024
Statement of administrator's proposal
Submitted on 18 May 2024
Registered office address changed from Biodata Innovation Centre Wellcome Genome Campus Hinxton Cambridge Cambridgeshire CB10 1DR England to 10 Lower Thames Street London EC3R 6AF on 4 April 2024
Submitted on 4 Apr 2024
Appointment of an administrator
Submitted on 4 Apr 2024
Termination of appointment of John Schoellerman as a director on 8 February 2024
Submitted on 23 Feb 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year